Last reviewed · How we verify
evaluation of propofol effect using BIS
At a glance
| Generic name | evaluation of propofol effect using BIS |
|---|---|
| Also known as | evaluation of effect of intravenous di-isopropilfenol |
| Sponsor | Universidad del Desarrollo |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intravenous Administration of Magnesium Sulfate in Laparoscopic Hysterectomy Cases (NA)
- A Comparative Study of Eleveld and Schnider Pharmacokinetic Models for Target-Controlled Infusion of Propofol in Sedation of Mechanically Ventilated ICU Patients
- Reevaluation Prediction of the Effect Site Propofol Eleveld Model Using Slow and Fast Induction
- Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes (NA)
- Comparison of TIVA by Closed Loop Anaesthesia Delivery System Versus Target Controlled Infusion Device (NA)
- Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases (NA)
- Manually Controlled Infusion Vs Target Controlled Infusion for StrokeThrombectomy (NA)
- Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: